GetTopicDetailResponse(id=a1b568e39e5, topicName=瑞舒伐他汀, introduction=瑞舒伐他汀, content=null, image=null, comments=1, allHits=1678, url=https://h5.medsci.cn/topic?id=68739, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=2136, tagList=[TagDto(tagId=2136, tagName=瑞舒伐他汀)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1241730, encodeId=2aa21241e30b9, content=20mg/d的<a href='/topic/show?id=a1b568e39e5' target=_blank style='color:#2F92EE;'>#瑞舒伐他汀#</a>可顯著降低中國(guó)成年亞臨床<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#動(dòng)脈粥樣硬化#</a>患者2年內(nèi)的<a href='/topic/show?id=c0924e16c0' target=_blank style='color:#2F92EE;'>#CIMT#</a>進(jìn)展，且耐受性良好。其一，劑量是不是過(guò)大？其二，亞臨床需要治療？, objectTitle=Stroke：瑞舒伐他汀減緩頸動(dòng)脈內(nèi)膜-中層厚度的進(jìn)展, objectType=article, longId=737240, objectId=6ca3e37240ca, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220828/1661684254220_1739456.jpg, objectUrl=/article/show_article.do?id=6ca3e37240ca, replyNumber=0, likeNumber=133, createdTime=2022-08-29, rootId=0, userName=循證小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ca3e37240ca, moduleTitle=Stroke：瑞舒伐他汀減緩頸動(dòng)脈內(nèi)膜-中層厚度的進(jìn)展, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6ca3e37240ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
